Get Patent Opposition Report for Neuraxpharm Arzneimittel

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Neuraxpharm Arzneimittel against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2959894S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISMar 22, 2023
EP2653873Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAJul 20, 2022
EP3103443Method For Treating Primary InsomniaNEURIM PHARMACEUTICALSMar 29, 2022